APA (7th ed.) Citation

T, T., JSY, H., CH, S., NA, L., YF, C., AYL, L., . . . BYQ, T. (2022). Sodium-glucose cotransporter 2 inhibitors and neurological disorders: A scoping review. Therapeutic advances in chronic disease, 13, 20406223221086996. https://doi.org/10.1177/20406223221086996

Chicago Style (17th ed.) Citation

T, Tharmaraja, et al. "Sodium-glucose Cotransporter 2 Inhibitors and Neurological Disorders: A Scoping Review." Therapeutic Advances in Chronic Disease 13 (2022): 20406223221086996. https://doi.org/10.1177/20406223221086996.

MLA (9th ed.) Citation

T, Tharmaraja, et al. "Sodium-glucose Cotransporter 2 Inhibitors and Neurological Disorders: A Scoping Review." Therapeutic Advances in Chronic Disease, vol. 13, 2022, p. 20406223221086996, https://doi.org/10.1177/20406223221086996.